Your browser doesn't support javascript.
loading
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Leslie, Kimberly K; Filiaci, Virginia L; Mallen, Adrianne R; Thiel, Kristina W; Devor, Eric J; Moxley, Katherine; Richardson, Debra; Mutch, David; Secord, Angeles Alvarez; Tewari, Krishnansu S; McDonald, Megan E; Mathews, Cara; Cosgrove, Casey; Dewdney, Summer; Casablanca, Yovanni; Jackson, Amanda; Rose, Peter G; Zhou, XunClare; McHale, Michael; Lankes, Heather; Levine, Douglas A; Aghajanian, Carol.
Afiliação
  • Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA. Electronic address: Kimberly-leslie@uiowa.edu.
  • Filiaci VL; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Electronic address: FiliaciV@NRGOncology.org.
  • Mallen AR; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA.
  • Thiel KW; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA. Electronic address: kristina-thiel@uiowa.edu.
  • Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA. Electronic address: eric-devor@uiowa.edu.
  • Moxley K; Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA. Electronic address: Katherine-moxley@ouhsc.edu.
  • Richardson D; Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
  • Mutch D; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63108, USA. Electronic address: mutchd@wustl.edu.
  • Secord AA; Duke University Institute, Duke University Health System, Durham, NC 27710, USA. Electronic address: angeles.secord@duke.edu.
  • Tewari KS; University of California Irvine Medical Center, Irvine, CA 92868, USA. Electronic address: ktewari@uci.edu.
  • McDonald ME; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA. Electronic address: megan-e-mcdonald@uiowa.edu.
  • Mathews C; Women and Infants Hospital in Rhode Island/The Warren Alpert Medical School of Brown University, Providence, RI 02905, USA. Electronic address: cmathews@wihri.org.
  • Cosgrove C; James Cancer Hospital and Solove Research Institute, Obstetrics and Gynecology, Ohio State University Medical Center, Columbus, OH 43210, USA. Electronic address: casey.cosgrove@osumc.edu.
  • Dewdney S; Gynecology, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: Summer_Dewdney@rush.edu.
  • Casablanca Y; Gynecology, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA. Electronic address: yovanni.casablanca.mil@mail.mil.
  • Jackson A; Gynecologic Oncology Center, University of Cincinnati Cancer Institute, Cincinnati, OH 45219, USA. Electronic address: jacks2a6@uc.mail.uc.edu.
  • Rose PG; Cleveland Clinic Foundation and Case Western Reserve University, Cleveland, OH 44195, USA. Electronic address: rosep@ccf.org.
  • Zhou X; Department of Gynecology, Hospital of Central Connecticut, New Britain, CT 06451, USA. Electronic address: XunClare.Zhou@hhchealth.org.
  • McHale M; Department of Gynecology, University of California San Diego, La Jolla, CA 92037, USA. Electronic address: mtmchale@health.ucsd.edu.
  • Lankes H; Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. Electronic address: LankesH@NRGOncology.org.
  • Levine DA; Gynecologic Oncology, NYU Langone Health, 240 E 38th St 19th Floor, New York, NY 10016, USA. Electronic address: Douglas.Levine@nyumc.org.
  • Aghajanian C; Memorial Sloan Kettering Cancer and Weill Cornell Medical Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: aghajanc@mskcc.org.
Gynecol Oncol ; 161(1): 113-121, 2021 04.
Article em En | MEDLINE | ID: mdl-33541735
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Neoplasias do Endométrio / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Neoplasias do Endométrio / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article